Muscular dystrophy breakthrough: FDA approves first-ever gene therapy for rare children’s disease

2 years ago 20

The FDA has approved the first gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in children 4-5 years of age. Get the details on how Elevidys could help pediatric patients.

1. Homepage
2. National News
3. Muscular dystrophy breakthrough: FDA approves first-ever gene therapy for rare children’s disease